Prominent phenotypic variability associated with mutations in Progranulin

Neurobiology of Aging

Volumn 30, Issue 5, 2009, Pages 739-751

  Kelley, Brendan J ^a   Haidar, Wael ^a   Boeve, Bradley F ^a   Baker, Matt ^b   Graff Radford, Neill R ^b   Krefft, Thomas ^c   Frank, Andrew R ^a   Jack Jr , Clifford R ^a   Shiung, Maria ^a   Knopman, David S ^a   Josephs, Keith A ^a   Parashos, Sotirios A ^d   Rademakers, Rosa ^b   Hutton, Mike ^b   Pickering Brown, Stuart ^e   Adamson, Jennifer ^b   Kuntz, Karen M ^a   Dickson, Dennis W ^b   Parisi, Joseph E ^a   Smith, Glenn E ^a   Ivnik, Robert J ^a   Petersen, Ronald C ^a   more..

^a MAYO CLINIC   (United States)

^b MAYO CLINIC   (United States)

^c Neurology Clinic   (United States)

^d Struthers Parkinson's Center   (United States)

^e UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Frontotemporal dementia; FTDP 17; MRI; PGRN; Progranulin

Indexed keywords

PROGRANULIN;

ADULT; AGED; ALZHEIMER DISEASE; ARTICLE; BRAIN ATROPHY; BRAIN DISEASE; CLINICAL ARTICLE; CORTICOBASAL SYNDROME; FEMALE; FRONTOTEMPORAL DEMENTIA; GENE MUTATION; GENETIC ASSOCIATION; HEMISPHERE; HUMAN; MALE; MILD COGNITIVE IMPAIRMENT; NUCLEAR MAGNETIC RESONANCE IMAGING; PARKINSONISM; PHENOTYPE; PRIMARY PROGRESSIVE APHASIA; PRIORITY JOURNAL;

AGE OF ONSET; AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; APHASIA, PRIMARY PROGRESSIVE; BRAIN; CEREBRAL CORTEX; DEMENTIA; DNA MUTATIONAL ANALYSIS; FEMALE; FUNCTIONAL LATERALITY; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUTATION; PARKINSONIAN DISORDERS; PHENOTYPE;

EID: 62349102691     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2007.08.022     Document Type: Article

References (54)

1. Baba Y., Tsuboi Y., Baker M.C., Uitti R.J., Hutton M.L., Dickson D.W., Farrer M., Putzke J.D., Woodruff B.K., Ghetti B., Murrell J.R., Boeve B.F., Petersen R.C., Verpillat P., Brice A., Delisle M.B., Rascol O., Arima K., Dysken M.W., Yasuda M., Kobayashi T., Sunohara N., Komure O., Kuno S., Sperfeld A.D., Stoppe G., Kohlhase J., Pickering-Brown S., Neary D., Bugiani O., and Wszolek Z.K. The effect of tau genotype on clinical features in ftdp-17. Parkinsonism Relat. Disord. 11 4 (2005) 205-208
2. Baba Y., Baker M.C., Le Ber I., Brice A., Maeck L., Kohlhase J., Yasuda M., Stoppe G., Bugiani O., Sperfeld A.D., Tsuboi Y., Uitti R.J., Farrer M.J., Ghetti B., Hutton M.L., and Wszolek Z.K. Clinical and genetic features of families with frontotemporal dementia and parkinsonism linked to chromosome 17 with a p301s tau mutation. J. Neural. Transm. (2007) (Epub ahead of print)
3. Baker M., Mackenzie I.R., Pickering-Brown S.M., Gass J., Rademakers R., Lindholm C., Snowden J., Adamson J., Sadovnick A.D., Rollinson S., Cannon A., Dwosh E., Neary D., Melquist S., Richardson A., Dickson D., Berger Z., Eriksen J., Robinson T., Zehr C., Dickey C.A., Crook R., McGowan E., Mann D., Boeve B., Feldman H., and Hutton M. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442 7105 (2006) 916-919
4. Basun H., Almkvist O., Axelman K., Brun A., Campbell T.A., Collinge J., Forsell C., Froelich S., Wahlund L.O., Wetterberg L., and Lannfelt L. Clinical characteristics of a chromosome 17-linked rapidly progressive familial frontotemporal dementia. Arch. Neurol. 54 5 (1997) 539-544
5. Benussi L., Binetti G., Sina E., Gigola L., Bettecken T., Meitinger T., and Ghidoni R. A novel deletion in progranulin gene is associated with FTDP-17 and CBS. Neurobiol. Aging (2006) (Epub ahead of print)
6. Bird T.D., Nochlin D., Poorkaj P., Cherrier M., Kaye J., Payami H., Peskind E., Lampe T.H., Nemens E., Boyer P.J., and Schellenberg G.D. A clinical pathological comparison of three families with frontotemporal dementia and identical mutations in the tau gene (P301l). Brain 122 Pt 4 (1999) 741-756
7. Boeve B.F., Maraganore D.M., Parisi J.E., Ivnik R.J., Westmoreland B.F., Dickson D.W., Hutton M., Hardy J., Caselli R.J., and Petersen R.C. Corticobasal degeneration and frontotemporal dementia presentations in a kindred with nonspecific histopathology. Dement. Geriatr. Cogn. Disord. 13 2 (2002) 80-90
8. Boeve B.F., Lang A.E., and Litvan I. Corticobasal degeneration and its relationship to progressive supranuclear palsy and frontotemporal dementia. Ann. Neurol. 54 Suppl. 5 (2003) S15-S19
9. Boeve B.F., Tremont-Lukats I.W., Waclawik A.J., Murrell J.R., Hermann B., Jack Jr. C.R., Shiung M.M., Smith G.E., Nair A.R., Lindor N., Koppikar V., and Ghetti B. Longitudinal characterization of two siblings with frontotemporal dementia and parkinsonism linked to chromosome 17 associated with the s305n tau mutation. Brain 128 Pt 4 (2005) 752-772
10. Boeve B.F., Baker M., Dickson D.W., Parisi J.E., Giannini C., Josephs K.A., Hutton M., Pickering-Brown S.M., Rademakers R., Tang-Wai D., Jack Jr. C.R., Kantarci K., Shiung M.M., Golde T., Smith G.E., Geda Y.E., Knopman D.S., and Petersen R.C. Frontotemporal dementia and parkinsonism associated with the IVS1 + 1G → A mutation in progranulin: a clinicopathologic study. Brain 129 Pt 11 (2006) 3103-3114
11. Brown J., Lantos P.L., and Rossor M.N. Familial dementia lacking specific pathological features presenting with clinical features of corticobasal degeneration. J. Neurol. Neurosurg. Psychiatry 65 4 (1998) 600-603
12. Brown J., Gydesen S., Johannsen P., Gade A., Skibinski G., Chakrabarti L., Brun A., Spillantini M., Yancopoulou D., Thusgaard T., Sorensen A., Fisher E., and Collinge J. Frontotemporal dementia linked to chromosome 3. Dement. Geriatr. Cogn. Disord. 17 4 (2004) 274-276
13. Bugiani O., Murrell J.R., Giaccone G., Hasegawa M., Ghigo G., Tabaton M., Morbin M., Primavera A., Carella F., Solaro C., Grisoli M., Savoiardo M., Spillantini M.G., Tagliavini F., Goedert M., and Ghetti B. Frontotemporal dementia and corticobasal degeneration in a family with a p301s mutation in tau. J. Neuropathol. Exp. Neurol. 58 6 (1999) 667-677
14. Cruts M., Gijselinck I., van der Zee J., Engelborghs S., Wils H., Pirici D., Rademakers R., Vandenberghe R., Dermaut B., Martin J.J., van Duijn C., Peeters K., Sciot R., Santens P., De Pooter T., Mattheijssens M., Van den Broeck M., Cuijt I., Vennekens K., De Deyn P.P., Kumar-Singh S., and Van Broeckhoven C. Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442 7105 (2006) 920-924
15. Forman M.S., Mackenzie I.R., Cairns N.J., Swanson E., Boyer P.J., Drachman D.A., Jhaveri B.S., Karlawish J.H., Pestronk A., Smith T.W., Tu P.H., Watts G.D., Markesbery W.R., Smith C.D., and Kimonis V.E. Novel ubiquitin neuropathology in frontotemporal dementia with valosin-containing protein gene mutations. J. Neuropathol. Exp. Neurol. 65 6 (2006) 571-581
16. Foster N.L., Wilhelmsen K., Sima A.A., Jones M.Z., D'Amato C.J., and Gilman S. Frontotemporal dementia and parkinsonism linked to chromosome 17: a consensus conference. Conference participants. Ann. Neurol. 41 6 (1997) 706-715
17. Frank A.R., Wszolek Z.K., Jack Jr. C.R., and Boeve B.F. Distinctive MRI findings in pallidopontonigral degeneration (PPND). Neurology 68 8 (2007) 620-621
18. Gass J., Cannon A., Mackenzie I.R., Boeve B., Baker M., Adamson J., Crook R., Melquist S., Kuntz K., Petersen R., Josephs K., Brown S.P., Graff-Radford N., Uitti R., Dickson D., Wzsolek Z., Gonzalez J., Beach T.G., Bigio E., Johnson N., Weintraub S., Mesulam M., White III C.L., Woodruff B., Caselli R., Hsiung G.Y., Feldman H., Knopman D., Hutton M., and Rademakers R. Mutations in progranulin are a major cause of ubiquitin-positive frontotemporal lobar degeneration. Hum. Mol. Genet. 15 20 (2006) 2988-3001
19. Goldfarb L.G., Petersen R.B., Tabaton M., Brown P., LeBlanc A.C., Montagna P., Cortelli P., Julien J., Vital C., Pendelbury W.W., et al. Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258 5083 (1992) 806-808
20. Grimes D.A., Bergeron C.B., and Lang A.E. Motor neuron disease-inclusion dementia presenting as cortical-basal ganglionic degeneration. Mov. Disord. 14 4 (1999) 674-680
21. Huey E.D., Grafman J., Wassermann E.M., Pietrini P., Tierney M.C., Ghetti B., Spina S., Baker M., Hutton M., Elder J.W., Berger S.L., Heflin K.A., Hardy J., and Momeni P. Characteristics of frontotemporal dementia patients with a progranulin mutation. Ann. Neurol. 60 3 (2006) 374-380
22. Hutton M., Lendon C.L., Rizzu P., Baker M., Froelich S., Houlden H., Pickering-Brown S., Chakraverty S., Isaacs A., Grover A., Hackett J., Adamson J., Lincoln S., Dickson D., Davies P., Petersen R.C., Stevens M., de Graaff E., Wauters E., van Baren J., Hillebrand M., Joosse M., Kwon J.M., Nowotny P., Che L.K., Norton J., Morris J.C., Reed L.A., Trojanowski J., Basun H., Lannfelt L., Neystat M., Fahn S., Dark F., Tannenberg T., Dodd P.R., Hayward N., Kwok J.B., Schofield P.R., Andreadis A., Snowden J., Craufurd D., Neary D., Owen F., Oostra B.A., Hardy J., Goate A., van Swieten J., Mann D., Lynch T., and Heutink P. Association of missense and 5′-splice-site mutations in tau with the inherited dementia FTDP-17. Nature 393 6686 (1998) 702-705
23. Ingram E.M., and Spillantini M.G. Tau gene mutations: dissecting the pathogenesis of FTDP-17. Trends Mol. Med. 8 12 (2002) 555-562
24. Josephs K.A., Holton J.L., Rossor M.N., Godbolt A.K., Ozawa T., Strand K., Khan N., Al-Sarraj S., and Revesz T. Frontotemporal lobar degeneration and ubiquitin immunohistochemistry. Neuropathol. Appl. Neurobiol. 30 4 (2004) 369-373
25. Josephs K.A., Parisi J.E., Knopman D.S., Boeve B.F., Petersen R.C., and Dickson D.W. Clinically undetected motor neuron disease in pathologically proven frontotemporal lobar degeneration with motor neuron disease. Arch. Neurol. 63 4 (2006) 506-512
26. Josephs K.A., Petersen R.C., Knopman D.S., Boeve B.F., Whitwell J.L., Duffy J.R., Parisi J.E., and Dickson D.W. Clinicopathologic analysis of frontotemporal and corticobasal degenerations and PSP. Neurology 66 1 (2006) 41-48
27. Josephs K.A., Ahmed Z., Katsuse O., Parisi J.F., Boeve B.F., Knopman D.S., Petersen R.C., Davies P., Duara R., Graff-Radford N.R., Uitti R.J., Rademakers R., Adamson J., Baker M., Hutton M.L., and Dickson D.W. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions with progranulin gene (PGRN) mutations. J. Neuropathol. Exp. Neurol. 66 2 (2007) 142-151
28. Kertesz A., Kawarai T., Rogaeva E., St George-Hyslop P., Poorkaj P., Bird T.D., and Munoz D.G. Familial frontotemporal dementia with ubiquitin-positive, tau-negative inclusions. Neurology 54 4 (2000) 818-827
29. Kertesz A., McMonagle P., Blair M., Davidson W., and Munoz D.G. The evolution and pathology of frontotemporal dementia. Brain 128 Pt 9 (2005) 1996-2005
30. Knopman D.S., Mastri A.R., Frey II W.H., Sung J.H., and Rustan T. Dementia lacking distinctive histologic features: a common non-Alzheimer degenerative dementia. Neurology 40 2 (1990) 251-256
31. Lipton A.M., White III C.L., and Bigio E.H. Frontotemporal lobar degeneration with motor neuron disease-type inclusions predominates in 76 cases of frontotemporal degeneration. Acta Neuropathol. (Berl.) 108 5 (2004) 379-385
32. Mackenzie I.R., Baker M., Pickering-Brown S., Hsiung G.Y., Lindholm C., Dwosh E., Gass J., Cannon A., Rademakers R., Hutton M., and Feldman H.H. The neuropathology of frontotemporal lobar degeneration caused by mutations in the progranulin gene. Brain 129 Pt 11 (2006) 3081-3090
33. Mackenzie I.R., Baker M., West G., Woulfe J., Qadi N., Gass J., Cannon A., Adamson J., Feldman H., Lindholm C., Melquist S., Pettman R., Sadovnick A.D., Dwosh E., Whiteheart S.W., Hutton M., and Pickering-Brown S.M. A family with tau-negative frontotemporal dementia and neuronal intranuclear inclusions linked to chromosome 17. Brain 129 Pt 4 (2006) 853-867
34. Mackenzie I.R., Shi J., Shaw C.L., Duplessis D., Neary D., Snowden J.S., and Mann D.M. Dementia lacking distinctive histology (DLDH) revisited. Acta Neuropathol. (Berl.) 112 5 (2006) 551-559
35. Masellis M., Momeni P., Meschino W., Heffner Jr. R., Elder J., Sato C., Liang Y., St George-Hyslop P., Hardy J., Bilbao J., Black S., and Rogaeva E. Novel splicing mutation in the progranulin gene causing familial corticobasal syndrome. Brain 129 Pt 11 (2006) 3115-3123
36. McKeith I.G., Dickson D.W., Lowe J., Emre M., O'Brien J.T., Feldman H., Cummings J., Duda J.E., Lippa C., Perry E.K., Aarsland D., Arai H., Ballard C.G., Boeve B., Burn D.J., Costa D., Del Ser T., Dubois B., Galasko D., Gauthier S., Goetz C.G., Gomez-Tortosa E., Halliday G., Hansen L.A., Hardy J., Iwatsubo T., Kalaria R.N., Kaufer D., Kenny R.A., Korczyn A., Kosaka K., Lee V.M., Lees A., Litvan I., Londos E., Lopez O.L., Minoshima S., Mizuno Y., Molina J.A., Mukaetova-Ladinska E.B., Pasquier F., Perry R.H., Schulz J.B., Trojanowski J.Q., and Yamada M. Diagnosis and management of dementia with Lewy bodies: third report of the DLB consortium. Neurology 65 12 (2005) 1863-1872
37. McKhann G.M., Albert M.S., Grossman M., Miller B., Dickson D., and Trojanowski J.Q. Clinical and pathological diagnosis of frontotemporal dementia: report of the work group on frontotemporal dementia and Pick's disease. Arch. Neurol. 58 11 (2001) 1803-1809
38. Meiner Z., Newman J.P., Rosenman H., Soffer D., and Steiner I. Frontotemporal dementia with ubiquitinated neuronal inclusions and visuospatial impairment. Neurology 65 3 (2005) 478-480
39. Members of the Department of Neurology, M.C., 1998. Clinical examinations in neurology. Mosby, St. Louis.
40. Mesulam M., Johnson N., Krefft T.A., Gass J.M., Cannon A.D., Adamson J.L., Bigio E.H., Weintraub S., Dickson D.W., Hutton M.L., and Graff-Radford N.R. Progranulin mutations in primary progressive aphasia: the PPA1 and PPA3 families. Arch. Neurol. 64 1 (2007) 43-47
41. Mukherjee O., Pastor P., Cairns N.J., Chakraverty S., Kauwe J.S., Shears S., Behrens M.I., Budde J., Hinrichs A.L., Norton J., Levitch D., Taylor-Reinwald L., Gitcho M., Tu P.H., Tenenholz Grinberg L., Liscic R.M., Armendariz J., Morris J.C., and Goate A.M. HDDD2 is a familial frontotemporal lobar degeneration with ubiquitin-positive, tau-negative inclusions caused by a missense mutation in the signal peptide of progranulin. Ann. Neurol. 60 3 (2006) 314-322
42. Neary D., Snowden J.S., Gustafson L., Passant U., Stuss D., Black S., Freedman M., Kertesz A., Robert P.H., Albert M., Boone K., Miller B.L., Cummings J., and Benson D.F. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. Neurology 51 6 (1998) 1546-1554
43. Neumann M., Sampathu D.M., Kwong L.K., Truax A.C., Micsenyi M.C., Chou T.T., Bruce J., Schuck T., Grossman M., Clark C.M., McCluskey L.F., Miller B.L., Masliah E., Mackenzie I.R., Feldman H., Feiden W., Kretzschmar H.A., Trojanowski J.Q., and Lee V.M. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314 5796 (2006) 130-133
44. Rademakers R., Cruts M., Dermaut B., Sleegers K., Rosso S.M., Van den Broeck M., Backhovens H., van Swieten J., van Duijn C.M., and Van Broeckhoven C. Tau negative frontal lobe dementia at 17q21: Significant finemapping of the candidate region to a 4.8 cm interval. Mol. Psychiatry 7 10 (2002) 1064-1074
45. Rosso S.M., Kamphorst W., de Graaf B., Willemsen R., Ravid R., Niermeijer M.F., Spillantini M.G., Heutink P., and van Swieten J.C. Familial frontotemporal dementia with ubiquitin-positive inclusions is linked to chromosome 17q21-22. Brain 124 Pt 10 (2001) 1948-1957
46. Savioz A., Riederer B.M., Heutink P., Rizzu P., Tolnay M., Kovari E., Probst A., Riederer I.M., Bouras C., and Leuba G. Tau and neurofilaments in a family with frontotemporal dementia unlinked to chromosome 17q21-22. Neurobiol. Dis. 12 1 (2003) 46-55
47. Skibinski G., Parkinson N.J., Brown J.M., Chakrabarti L., Lloyd S.L., Hummerich H., Nielsen J.E., Hodges J.R., Spillantini M.G., Thusgaard T., Brandner S., Brun A., Rossor M.N., Gade A., Johannsen P., Sorensen S.A., Gydesen S., Fisher E.M., and Collinge J. Mutations in the endosomal escrtii-complex subunit CHMP2b in frontotemporal dementia. Nat. Genet. 37 8 (2005) 806-808
48. Snowden J.S., Pickering-Brown S.M., Mackenzie I.R., Richardson A.M., Varma A., Neary D., and Mann D.M. Progranulin gene mutations associated with frontotemporal dementia and progressive non-fluent aphasia. Brain 129 Pt 11 (2006) 3091-3102
49. Spina S., Murrell J.R., Huey E.D., Wassermann E.M., Pietrini P., Baraibar M.A., Barbeito A.G., Troncoso J.C., Vidal R., Ghetti B., and Grafman J. Clinicopathologic features of frontotemporal dementia with progranulin sequence variation. Neurology 68 11 (2007) 820-827
50. Suzuki M., and Nishiahara M. Granulin precursor gene: a sex steroid-inducible gene involved in sexual differentiation of the rat brain. Mol. Genet. Metab. 75 1 (2002) 31-37
51. The National Institute on Aging, and Reagan Institute Working Group on Diagnostic Criteria for the Neuropathological Assessment of Alzheimer's disease. Consensus recommendations for the postmortem diagnosis of Alzheimer's disease. Neurobiol. Aging 18 4 Suppl. (1997) S1-S2
52. van der Zee J., Rademakers R., Engelborghs S., Gijselinck I., Bogaerts V., Vandenberghe R., Santens P., Caekebeke J., De Pooter T., Peeters K., Lubke U., Van den Broeck M., Martin J.J., Cruts M., De Deyn P.P., Van Broeckhoven C., and Dermaut B. A Belgian ancestral haplotype harbours a highly prevalent mutation for 17q21-linked tau-negative FTLD. Brain 129 Pt 4 (2006) 841-852
53. Vance C., Al-Chalabi A., Ruddy D., Smith B.N., Hu X., Sreedharan J., Siddique T., Schelhaas H.J., Kusters B., Troost D., Baas F., de Jong V., and Shaw C.E. Familial amyotrophic lateral sclerosis with frontotemporal dementia is linked to a locus on chromosome 9p13.2-21.3. Brain 129 Pt 4 (2006) 868-876
54. Whitwell J.L., Jack Jr. C.R., Baker M., Rademakers R., Adamson J., Boeve B.F., Knopman D.S., Parisi J.F., Petersen R.C., Dickson D.W., Hutton M.L., and Josephs K.A. Voxel-based morphometry in frontotemporal lobar degeneration with ubiquitin-positive inclusions with and without progranulin mutations. Arch. Neurol. 64 3 (2007) 371-376